Literature DB >> 19015443

Efficacy of tympanoplasty without mastoidectomy for chronic suppurative otitis media.

Benjamin D Webb1, C Y Joseph Chang.   

Abstract

OBJECTIVE: To compare the efficacy of tympanoplasty without mastoidectomy in patients with chronic suppurative otitis media (CSOM) vs efficacy in those with dry tympanic membrane (TM) perforations.
DESIGN: Retrospective controlled study based on a prospective database.
SETTING: Academic tertiary referral center. PATIENTS: A total of 150 consecutive patients without cholesteatoma with CSOM or dry perforations alone who underwent tympanoplasty without mastoidectomy from January 2000 through December 2005. INTERVENTION: Tympanoplasty without mastoidectomy. MAIN OUTCOME MEASURE: Perforation recurrence. Independent variables were age, surgical approach, perforation size, and revision surgery.
RESULTS: The TM graft failure rate was not significantly worse in the CSOM group compared with the dry perforation group (P = .48). The independent variables studied were not statistically related to the success of tympanoplasty except that revision surgery was associated with a slightly reduced success rate (P = .03).
CONCLUSIONS: The success rate of tympanoplasty without mastoidectomy is at least as good for patients with CSOM as it is for patients with perforation without prior otorrhea. Age (P = .28), perforation size (P = .11), and surgical approach (P = .82) were not significantly related to success rate. Revision surgery was associated with a slightly lower success rate.

Entities:  

Mesh:

Year:  2008        PMID: 19015443     DOI: 10.1001/archotol.134.11.1155

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  9 in total

1.  Efficacy of a topical suspension of bacterial antigens for the management of chronic suppurative otitis media.

Authors:  Renzo Mora; Francesco Antonio Salzano; Enzo Mora; Luca Guastini
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-29       Impact factor: 2.503

Review 2.  [Eustachian tube and middle ear mechanics].

Authors:  H W Pau
Journal:  HNO       Date:  2011-10       Impact factor: 1.284

3.  Does The Type of Ossicular Chain Lesion Affect Outcomes in Chronic Suppurative Otitis Media Without Cholesteatoma?

Authors:  Tamas Horvath; Dora Lukacs; Barnabas Horvath; Tamas Ferenci; Balint Liktor
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

4.  Study of Outcomes of Tympanoplasty Between Wet and Dry Ears in Mucosal Type of COM.

Authors:  Neha Sesodia; Puneet Bhargava; Anjana Agrawal; Sudhakar Vaidya
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-04-01

5.  Type 1 Revision Tympanoplasty Using Tragal Cartilage in a Tertiary Care Centre: A Prospective Observational Study.

Authors:  Kartik Irappa Patil; Ramabhadraiah Anil Kumar; Hosaagrahara Subbegowda Satish
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-01-28

Review 6.  Success rates for various graft materials in tympanoplasty - A review.

Authors:  Ali Bayram; Nuray Bayar Muluk; Cemal Cingi; Sameer Ali Bafaqeeh
Journal:  J Otol       Date:  2020-01-07

7.  Cartilage graft or fascia in tympanoplasty in patients with low middle ear risk index (anatomical and audological results).

Authors:  Elif Ersoy Callioglu; B Tijen Ceylan; Gokhan Kuran; Sule Demirci; Kamil Gokce Tulaci; Refik Caylan
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-25       Impact factor: 2.503

8.  Comparison of Grafting Success Rate and Hearing Outcomes between Primary and Revision Tympanoplasties.

Authors:  Mohammad Faramarzi; Mahmood Shishegar; Saeed Reza Tofighi; Hadi Sharouny; Raman Rajagopalan
Journal:  Iran J Otorhinolaryngol       Date:  2019-01

9.  Efficacy of Tympanoplasty Without Mastoidectomy for Treating Chronic Otitis Media in Patients With Mastoid Cavity Opacification in Temporal Bone Computed Tomography Findings.

Authors:  Hantai Kim; Ho Young Bae; Oak-Sung Choo; Yun-Hoon Choung
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-02-22       Impact factor: 3.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.